The opposite effect of ELP4 and ZEB2 on TCF7L2-mediated microglia polarization in ischemic stroke

Xiao-Li Min1, Sixian Lin1, Jia-Yi Hu1

  • 1Department of Cerebrovascular Diseases The Second Affiliated Hospital of Kunming Medical University Kunming China.

Insights

Transcription factor 7 like 2 (TCF7L2) exacerbates ischemic stroke injury by promoting M1 microglia polarization. ELP4 enhances TCF7L2 expression, while ZEB2 promotes its degradation, impacting stroke outcomes.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia M1 polarization is crucial in ischemic stroke (IS) pathogenesis.
  • Understanding the regulatory mechanisms of microglia polarization is vital for IS treatment.

Purpose of the Study:

  • To investigate the role of transcription factor 7 like 2 (TCF7L2) in regulating microglia M1 polarization during IS.
  • To elucidate the molecular mechanisms by which TCF7L2 influences IS progression.

Main Methods:

  • Cerebral infarction assessed by TTC staining; neuronal injury by Nissl staining.
  • Cytokine levels measured by ELISA.
  • Protein interactions (ZEB2-TCF7L2) analyzed by Co-IP; TCF7L2 promoter activity by ChIP assay.

Main Results:

  • TCF7L2 knockdown reduced MCAO/R-induced cerebral injury and OGD/R-induced microglia M1 polarization via the TLR4/NF-κB pathway.
  • TCF7L2 promotes TLR4 transcription; ELP4 enhances TCF7L2 expression via H3K27ac enrichment.
  • ZEB2 promotes TCF7L2 degradation through ubiquitination, counteracting ELP4's effect.

Conclusions:

  • TCF7L2 exacerbates IS by promoting microglia M1 polarization.
  • ELP4-mediated epigenetic regulation and ZEB2-mediated degradation are key modulators of TCF7L2 levels and function in IS.
  • Targeting TCF7L2 presents a potential therapeutic strategy for ischemic stroke.